[1]
R. Quilty, K. Smith, D. Jones, and S. Drover, “Rituximab and Immune Molecule Modulation in Burkitt’s Lymphoma Cell Lines”, UOJM, vol. 9, no. 1, pp. 33–39, May 2019.